Literature DB >> 33422007

Factors associated with elevated alanine aminotransferase in employees of a German chemical company: results of a large cross-sectional study.

Matthias Claus1, Christoph Antoni2, Bernd Hofmann3.   

Abstract

BACKGROUND: We aimed to determine the prevalence of elevated alanine aminotransferase (eALT) in employees of a German chemical company, and analyze its association with sociodemographic, work- and lifestyle-related factors.
METHODS: The cross-sectional study is based on data surveyed from occupational health check-ups between 2013 and 2018 at the site clinic of a chemical company based in Ludwigshafen, Germany. We used logistic regression analyses to assess the association between sociodemographic, work- and lifestyle-related characteristics and eALT. Quantile regression technique was applied to investigate if associations vary across different quantiles of the ALT distribution.
RESULTS: Participants (n = 15,348) were predominantly male (78.3%) with a mean age of 42.2 years (SD 10.7). The prevalence of eALT was 18.5% (21.6% in men/7.2% in women) with a geometric mean of 28.9 U/L (32.8 U/L in men/18.5 U/L in women). In the multivariable logistic regression model, odds of eALT were significantly higher for males (OR 2.61; 95%-CI 2.24-3.05), manual workers (OR 1.23; 95%-CI 1.06-1.43), overweight (OR 2.66; 95%-CI 2.36-3.00) or obese respondents (e.g. OR 7.88; 95%-CI 5.75-10.80 for obesity class III), employees who consume any number of alcoholic drinks/week (e.g. OR 1.32; 95%-CI 1.16-1.49 for ≥ 3 drinks per week) and diabetics (OR 1.47; 95%-CI 1.22-1.78). Additionally, season of participation was significantly associated with eALT, with odds being higher for participation in spring, fall or winter, as compared to summer. A significant interaction between age and gender (pInteraction < 0.001) was found, showing approximately a u-shaped age/ALT relationship in women and an inversely u-shaped relationship in men. Quantile regression showed an increasing positive effect of male gender, overweight/obesity, and for diabetics on ALT level when moving from the lowest (q0.1) to the highest (q0.9) considered quantile. Additionally, from the lowest to the highest quantile an increasing negative effect on ALT for older age was observed.
CONCLUSIONS: Prevalence of eALT in our sample of employees can be considered as high, with almost one in five participants affected. Identification of risk groups allows the implementation of targeted preventive measures in order to avoid transition to severe morbidity.

Entities:  

Keywords:  Alanine aminotransferase; Cross-sectional study; Employees; Germany; Liver enzymes; Non-alcoholic fatty liver disease; Prevalence; Quantile regression; Serum transaminase; Social determinants

Mesh:

Substances:

Year:  2021        PMID: 33422007      PMCID: PMC7797104          DOI: 10.1186/s12876-021-01601-2

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  51 in total

1.  PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.

Authors:  Elizabeth K Speliotes; Johannah L Butler; Cameron D Palmer; Benjamin F Voight; Joel N Hirschhorn
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

2.  Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population.

Authors:  Toshiaki Gunji; Nobuyuki Matsuhashi; Hajime Sato; Kazutoshi Fujibayashi; Mitsue Okumura; Noriko Sasabe; Akio Urabe
Journal:  Am J Gastroenterol       Date:  2009-06-23       Impact factor: 10.864

3.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Authors:  Mattias Ekstedt; Hannes Hagström; Patrik Nasr; Mats Fredrikson; Per Stål; Stergios Kechagias; Rolf Hultcrantz
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

4.  Smoking is not associated with nonalcoholic fatty liver disease.

Authors:  Norberto-C Chavez-Tapia; Javier Lizardi-Cervera; Oliver Perez-Bautista; Martha H Ramos-Ostos; Misael Uribe
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

5.  Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults.

Authors:  Seung H Park; Woo K Jeon; Sang H Kim; Hong J Kim; Dong I Park; Yong K Cho; In K Sung; Chong I Sohn; Dong K Keum; Byung I Kim
Journal:  J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 4.029

6.  The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.

Authors:  George N Ioannou; Edward J Boyko; Sum P Lee
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

7.  Serum levels of alanine aminotransferase decrease with age in longitudinal analysis.

Authors:  Mamie H Dong; Ricki Bettencourt; David A Brenner; Elizabeth Barrett-Connor; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2011-10-20       Impact factor: 11.382

8.  Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.

Authors:  Yuichiro Eguchi; Hideyuki Hyogo; Masafumi Ono; Toshihiko Mizuta; Naofumi Ono; Kazuma Fujimoto; Kazuaki Chayama; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2012-02-11       Impact factor: 7.527

Review 9.  Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.

Authors:  Hannele Yki-Järvinen
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-07       Impact factor: 32.069

10.  Relationship between shift work and liver enzymes: a cross-sectional study based on the Korea National Health and Examination Survey (2007-2015).

Authors:  Hyeongyeong Choi; Hyun-Jeong Oh; Ji-Su Shin; MyeongSeob Lim; Sung-Kyung Kim; Hee-Tae Kang; Sung-Soo Oh; Sang-Baek Koh
Journal:  Ann Occup Environ Med       Date:  2019-07-31
View more
  2 in total

1.  Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population-Based Study in Germany.

Authors:  Karl J Lackner; Jörn M Schattenberg; Yvonne Huber; Andreas Schulz; Irene Schmidtmann; Manfred Beutel; Norbert Pfeiffer; Thomas Münzel; Peter R Galle; Philipp S Wild
Journal:  Hepatol Commun       Date:  2022-02-05

2.  The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase.

Authors:  Hongwu Wang; Qin Ning; Yuting Diao; Danqing Hu; Xue Hu; Peng Wang; Xiaojing Wang; Xiaoping Luo
Journal:  Infect Dis Ther       Date:  2022-04-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.